[PDF][PDF] HIV genetic diversity informs stage of HIV-1 infection among patients receiving antiretroviral therapy in Botswana

M Ragonnet-Cronin, T Golubchik, S Moyo, C Fraser… - J Infect Dis, 2021 - scholar.archive.org
HIV genetic diversity informs stage of HIV-1 infection among patients receiving antiretroviral
therapy in Botswana Page 1 © The Author(s) 2021. Published by Oxford University Press for …

Human immunodeficiency virus (HIV) genetic diversity informs stage of HIV-1 infection among patients receiving antiretroviral therapy in Botswana

M Ragonnet-Cronin, T Golubchik… - The Journal of …, 2022 - academic.oup.com
Background Human immunodeficiency virus (HIV)-1 genetic diversity increases during
infection and can help infer the time elapsed since infection. However, the effect of …

Pairwise diversity and tMRCA as potential markers for HIV infection recency

S Moyo, E Wilkinson, A Vandormael, R Wang, J Weng… - Medicine, 2017 - journals.lww.com
Intrahost human immunodeficiency virus (HIV)-1 diversity increases linearly over time. We
assessed the extent to which mean pairwise distances and the time to the most recent …

Association between HIV genotype, viral load and disease progression in a cohort of Thai men who have sex with men with estimated dates of HIV infection

W Leelawiwat, S Pattanasin, A Sriporn, P Wasinrapee… - Plos one, 2018 - journals.plos.org
Background Differences between HIV genotypes may affect HIV disease progression. We
examined infecting HIV genotypes and their association with disease progression in a …

Genetic diversity from proviral DNA as a proxy for time since HIV-1 infection

M Zeeb, P Frischknecht, M Huber… - The Journal of …, 2024 - academic.oup.com
HIV-1 RNA genetic diversity predicts time since infection, which is important for clinical care
and research. It is unclear, however, whether proviral DNA genetic diversity sampled under …

Antiretroviral drug susceptibility among drug-naive adults with recent HIV infection in Rakai, Uganda

SH Eshleman, O Laeyendecker, N Parkin, W Huang… - Aids, 2009 - journals.lww.com
Objective: To analyze antiretroviral drug susceptibility in HIV from recently infected adults in
Rakai, Uganda, prior to the availability of antiretroviral drug treatment. Methods: Samples …

Different disease progression rate according to HIV-1 subtype

C de Mendoza, C Garrido - 2008 - Taylor & Francis
Evaluation of: Kiwanuka N, Laeyendecker O, Robb M et al.: Effect of human
immunodeficiency virus type 1 (HIV-1) subtype on disease progression in persons from …

Intrapatient diversity and its correlation with viral setpoint in human immunodeficiency virus type 1 CRF02_A/G-IbNG infection

I Mani, P Gilbert, JL Sankalé, G Eisen, S Mboup… - Journal of …, 2002 - Am Soc Microbiol
The human immunodeficiency virus type 1 (HIV-1) viral setpoint during the disease-free
interval has been strongly associated with future risk of disease progression. An awareness …

Analysis of viral diversity in relation to the recency of HIV-1C infection in Botswana

S Moyo, A Vandormael, E Wilkinson, S Engelbrecht… - PLoS …, 2016 - journals.plos.org
Background Cross-sectional, biomarker methods to determine HIV infection recency present
a promising and cost-effective alternative to the repeated testing of uninfected individuals …

Dynamic HIV-1 genetic recombination and genotypic drug resistance among treatment-experienced adults in northern Ghana

NI Nii-Trebi, JAM Brandful, S Ibe… - Journal of Medical …, 2017 - microbiologyresearch.org
Purpose. There have been hardly any reports on the human immunodeficiency virus type 1
(HIV-1) drug-resistance profile from northern Ghana since antiretroviral therapy (ART) was …